Request Demo
Last update 26 Jul 2025
PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor(Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.)
Last update 26 Jul 2025
Overview
Basic Info
Drug Type Biosimilar, Colony-stimulating factors |
Synonyms- |
Target |
Action agonists |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseSuspendedPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 4190
The sequence is quoted from: *****
Related
1
Clinical Trials associated with PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor(Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.)CTR20202194
聚乙二醇化重组人粒细胞刺激因子注射液I期临床试验
[Translation] Phase I clinical trial of pegylated recombinant human granulocyte-stimulating factor injection
100 Clinical Results associated with PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor(Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.)
Login to view more data
100 Translational Medicine associated with PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor(Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor(Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.)
Login to view more data
100 Deals associated with PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor(Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neutropenia | Phase 1 | China | 03 Dec 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | 41 | rtzbwxyutp(ymadntcibw) = lslghxpdwe sbnwtkcatr (wqbabwfczr ) | - | 21 Sep 2022 | |||
Not Applicable | - | 45 | CapeOX | xjgszunutd(gjvzegbnra) = teuphcohxs zmwcobbcxf (dyuxwwftct ) View more | - | 21 Sep 2022 | |
SOX | xjgszunutd(gjvzegbnra) = uzwvdvkbkq zmwcobbcxf (dyuxwwftct ) | ||||||
Not Applicable | 104 | netubxsmxe(qhbbblutms) = itcyingerf aqoywhkdym (nmjniyzzim ) View more | - | 19 Sep 2020 | |||
Not Applicable | 15 | ojvkkkiwih(yrzmdbrtsx) = doyaxgoddw hctnbqkfve (qwbfcnivbp ) | - | 19 Sep 2020 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free